⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Lost Money on Aardvark Therapeutics, Inc. (AARD)? Contact Levi & Korsinsky Before October 13, 2026 to Join Class Action
accessnewswire.com
AARD
Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. (AARD) Shareholders of Class Action Lawsuit and October 13, 2026 Deadline
accessnewswire.com
AARD
Shareholders of Aardvark Therapeutics, Inc. (AARD): Protect Your Rights Before October 13, 2026 - Contact Levi & Korsinsky
accessnewswire.com
AARD
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD
accessnewswire.com
AARD
Pomerantz LLP Announces The Filing of a Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
AARD
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
globenewswire.com
AARD
AARD UPCOMING DEADLINE: Levi & Korsinsky Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
globenewswire.com
AARD
Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately
prnewswire.com
AARD